Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 230,888 | 352,688 | 237,179 | 119,379 | 306,256 |
Marketable Securities | 11,407 | 0 | N/A | 45,035 | N/A |
Receivables | 15,686 | 8,397 | 1,305 | N/A | N/A |
Inventories | 1,096 | 979 | 419 | 6 | N/A |
Other current assets | 16,120 | 23,578 | 6,043 | 3,930 | 1,311 |
TOTAL | $275,197 | $385,642 | $244,946 | $168,350 | $307,567 |
Non-Current Assets | |||||
PPE Net | 254,082 | 203,027 | 108,777 | 7,681 | 6,611 |
Intangibles | 6,105 | 3,139 | 5,814 | 3,124 | 5,785 |
Other Non-Current Assets | 11,308 | 11,308 | 11,357 | 1,038 | 749 |
TOTAL | $271,495 | $217,474 | $125,948 | $11,843 | $13,145 |
Total Assets | $546,692 | $603,116 | $370,894 | $180,193 | $320,712 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 13,872 | 6,707 | 4,200 | 2,115 | 1,454 |
Accounts payable and accrued liabilities | 17,013 | 10,819 | 11,363 | 8,267 | 5,728 |
Accrued Expenses | 47,463 | 35,053 | 29,518 | 25,926 | 13,157 |
Other current liabilities | 24,324 | 17,830 | 15,136 | 698 | 136 |
TOTAL | $132,284 | $89,998 | $72,177 | $48,866 | $25,372 |
Non-Current Liabilities | |||||
Long Term Debt | 429,220 | 345,474 | 4,900 | 9,100 | 11,215 |
Deferred Revenues | 6,763 | 8,075 | 2,983 | 3,764 | 1,263 |
Other Non-Current Liabilities | 11,244 | 11,338 | 8,580 | 6,870 | 60,493 |
TOTAL | $517,549 | $432,317 | $113,200 | $18,476 | $75,199 |
Total Liabilities | $649,833 | $522,315 | $185,377 | $67,342 | $100,571 |
Shareholders' Equity | |||||
Shares Outstanding, K | 190,175 | 187,532 | 186,323 | 183,818 | 158,930 |
Common Shares | 190 | 187 | 186 | 167 | 158 |
Retained earnings | -1,445,751 | -1,214,595 | -1,051,993 | -777,835 | -556,963 |
Other shareholders' equity | 3,835 | -4,185 | -1,535 | 20 | 0 |
TOTAL | $-103,141 | $80,801 | $185,517 | $112,851 | $220,141 |
Total Liabilities And Equity | $546,692 | $603,116 | $370,894 | $180,193 | $320,712 |